The usefulness of delayed enhancement magnetic resonance imaging for diagnosis and evaluation of cardiac function in patients with cardiac sarcoidosis.

[1]  H. Sakahara,et al.  Usefulness of delayed enhancement magnetic resonance imaging to differentiate dilated phase of hypertrophic cardiomyopathy and dilated cardiomyopathy. , 2007, Journal of cardiac failure.

[2]  S. Kanao,et al.  Images in cardiovascular medicine. Multimodality imaging of cardiac sarcoidosis before and after steroid therapy. , 2006, Circulation.

[3]  H. Sakahara,et al.  Usefulness of delayed enhancement magnetic resonance imaging for detecting cardiac rupture caused by small myocardial infarction in a case of cardiac tamponade. , 2005, Circulation journal : official journal of the Japanese Circulation Society.

[4]  S. Kanao,et al.  Effectiveness of delayed enhanced MRI for identification of cardiac sarcoidosis: comparison with radionuclide imaging. , 2005, AJR. American journal of roentgenology.

[5]  W. Dassen,et al.  Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis. , 2005, Journal of the American College of Cardiology.

[6]  O. Vignaux.  Cardiac sarcoidosis: spectrum of MRI features. , 2005, AJR. American journal of roentgenology.

[7]  T. Yokoyama,et al.  Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[8]  Robert R Edelman,et al.  Contrast-enhanced MR imaging of the heart: overview of the literature. , 2004, Radiology.

[9]  P. Paule,et al.  Diagnosis de localisations cardiaques et suivi longitudinal de 24 sarcoïdoses , 2004 .

[10]  T. Nakano,et al.  Usefulness of stress myocardial perfusion imaging for evaluating asymptomatic patients after coronary stent implantation. , 2004, Circulation journal : official journal of the Japanese Circulation Society.

[11]  L. Fourcade,et al.  [Diagnosis of cardiac sarcoidosis and follow-up of 24 consecutive patients]. , 2004, La Revue de medecine interne.

[12]  L. V. Van Hoe,et al.  Ischemic cardiomyopathy: value of different MRI techniques for prediction of functional recovery after revascularization. , 2004, AJR. American journal of roentgenology.

[13]  M. Yoshiyama,et al.  Identification of cardiac sarcoidosis with (13)N-NH(3)/(18)F-FDG PET. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[14]  D. Pennell,et al.  Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. , 2003, Journal of the American College of Cardiology.

[15]  D. Dusser,et al.  Apport de l'IRM dans l'exploration de l'atteinte cardiaque au cours de la sarcoïdose , 2003 .

[16]  R. Kim,et al.  Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study , 2003, The Lancet.

[17]  O. Vignaux,et al.  [Value of MRI for the diagnosis of cardiac involvement in sarcoidosis]. , 2003, La Revue de medecine interne.

[18]  O. Vignaux,et al.  Clinical significance of myocardial magnetic resonance abnormalities in patients with sarcoidosis: a 1-year follow-up study. , 2002, Chest.

[19]  O. Vignaux,et al.  Detection of Myocardial Involvement in Patients with Sarcoidosis Applying T2-Weighted, Contrast-Enhanced, and Cine Magnetic Resonance Imaging: Initial Results of a Prospective Study , 2002, Journal of computer assisted tomography.

[20]  A. Tada.  [67Gallium whole body scintigraphy and single photon emission computed tomography(SPECT) in sarcoidosis]. , 2002, Nihon rinsho. Japanese journal of clinical medicine.

[21]  T. Takemura.  [Epithelioid cell granuloma in sarcoidosis: light and electron microscopic morphology]. , 2002, Nihon rinsho. Japanese journal of clinical medicine.

[22]  M. Isobe,et al.  Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone. , 2001, The American journal of cardiology.

[23]  R. Maruyama,et al.  Diagnosis of cardiac sarcoidosis and evaluation of the effects of steroid therapy by gadolinium-DTPA-enhanced magnetic resonance imaging. , 2001, The American journal of medicine.

[24]  C. Lorenz,et al.  Measurement of the gadopentetate dimeglumine partition coefficient in human myocardium in vivo: normal distribution and elevation in acute and chronic infarction. , 2001, Radiology.

[25]  Hiroyuki Okada,et al.  Short dynamic FDG-PET imaging protocol for patients with lung cancer , 2000, European Journal of Nuclear Medicine.

[26]  H. Hishida,et al.  Histologic diagnostic rate of cardiac sarcoidosis: evaluation of endomyocardial biopsies. , 1999, American heart journal.

[27]  P. Grenier,et al.  Sarcoidosis activity: correlation of HRCT findings with those of 67Ga scanning, bronchoalveolar lavage, and serum angiotensin-converting enzyme assay. , 1998, Journal of computer assisted tomography.

[28]  O. Sharma.  Cardiac and neurologic dysfunction in sarcoidosis. , 1997, Clinics in chest medicine.

[29]  R. Kim,et al.  Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction. , 1996, Circulation.

[30]  R. Pettigrew,et al.  Diagnosis of cardiac sarcoidosis aided by MRI. , 1996, Chest.

[31]  K. Chida,et al.  Diagnostic and prognostic value of myocardial scintigraphy with thallium-201 and gallium-67 in cardiac sarcoidosis. , 1995, Chest.

[32]  H. Tazelaar,et al.  Racial difference in cardiac sarcoidosis incidence observed at autopsy. , 1994, Sarcoidosis.

[33]  D. Berman,et al.  Separate acquisition rest thallium-201/stress technetium-99m sestamibi dual-isotope myocardial perfusion single-photon emission computed tomography: a clinical validation study. , 1993, Journal of the American College of Cardiology.

[34]  Y. Kawabata,et al.  Pathological studies on sarcoidosis autopsy. I. Epidemiological features of 320 cases in Japan , 1993, Acta pathologica japonica.

[35]  K. Riedy,et al.  MR imaging of myocardial sarcoidosis. , 1988, AJR. American journal of roentgenology.

[36]  W. Mckenna,et al.  Sarcoidosis: a pattern of clinical and morphological presentation. , 1987, British heart journal.

[37]  G. Johnston,et al.  Gallium-67 scanning to stage the alveolitis of sarcoidosis: correlation with clinical studies, pulmonary function studies, and bronchoalveolar lavage. , 1981, The American review of respiratory disease.

[38]  V. Abeler.  Sarcoidosis of the cardiac conducting system. , 1979, American heart journal.

[39]  G. Hutchins,et al.  Cardiac Sarcoid: A Clinicopathologic Study of 84 Unselected Patients with Systemic Sarcoidosis , 1978, Circulation.

[40]  J. Mason,et al.  Cardiac sarcoidosis: Diagnosis with endomyocardial biopsy and treatment with corticosteroids☆ , 1978 .